Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cardiol Rev. 2011 Mar-Apr;19(2):47-51. doi: 10.1097/CRD.0b013e3181fc1ae6.

RESPeRATE: nonpharmacological treatment of hypertension.

Author information

  • 1Department of Medicine, New York Medical College, Westchester Medical Center, Valhalla, NY 10595, USA.

Abstract

Systemic hypertension has been well documented as a major risk factor for premature cardiovascular morbidity and mortality. Reduction of high blood pressure (BP) by nonpharmacological means is widely recommended, either as a primary prevention therapy or as an adjunctive treatment with antihypertensive drugs. RESPeRATE is a commercially available electronic device that presents a novel nonpharmacological approach to the treatment of hypertension. RESPeRATE-guided slow-paced breathing aimed at achieving a respiratory frequency of <10 breaths per minute has been shown, in multiple studies, to reduce BP in hypertensive individuals by improving the autonomic balance through respiratory control. This article discusses RESPeRATE and the scientific evidence that supports the use of device-guided slow breathing to reduce BP.

PMID:
21285661
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk